Jaguar Health, INC. (JAGX) — 8-K Filings

All 8-K filings from Jaguar Health, INC.. Browse 41 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (41)

8-K Filing — Apr 21, 2026
Jaguar Health Files 8-K on Financials — Apr 7, 2026 Risk: medium
Jaguar Health, Inc. filed an 8-K on April 7, 2026, reporting on its results of operations and financial condition. The filing includes financial statements and
8-K Filing — Dec 12, 2025
Jaguar Health Files 8-K on Shareholder Votes & Financials — Dec 8, 2025 Risk: low
Jaguar Health, Inc. filed an 8-K on December 8, 2025, reporting on matters submitted to a vote of security holders, Regulation FD disclosures, and financial sta
Jaguar Health Files 8-K: Agreements, Obligations, Equity Sales — Nov 19, 2025 Risk: medium
On November 17, 2025, Jaguar Health, Inc. entered into a material definitive agreement. The company also incurred a direct financial obligation or an obligation
Jaguar Health Enters Material Definitive Agreement — Nov 14, 2025 Risk: medium
On November 14, 2025, Jaguar Health, Inc. entered into a material definitive agreement, creating a direct financial obligation. The company, formerly known as J
Jaguar Health Files 8-K on Equity Sales — Oct 3, 2025 Risk: medium
On September 30, 2025, Jaguar Health, Inc. filed an 8-K report detailing unregistered sales of equity securities. The company, formerly known as Jaguar Animal H
Jaguar Health Files 8-K: Material Agreement & Equity Sales — Oct 1, 2025 Risk: medium
On September 28, 2025, Jaguar Health, Inc. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities an
Jaguar Health Files 8-K: Agreements, Equity Sales, Bylaw Changes — Sep 11, 2025 Risk: medium
On September 9, 2025, Jaguar Health, Inc. filed an 8-K report detailing several key events. These include entering into a material definitive agreement, unregis
Jaguar Health Files 8-K: Corporate Updates — Aug 19, 2025 Risk: low
On August 19, 2025, Jaguar Health, Inc. filed an 8-K report detailing matters submitted to a vote of security holders, Regulation FD disclosures, and financial
Jaguar Health Files 8-K on Material Agreement — Aug 14, 2025 Risk: medium
On August 14, 2025, Jaguar Health, Inc. filed an 8-K report detailing a material definitive agreement. The filing also includes financial statements and exhibit
Jaguar Health Files 8-K: Material Agreements and Equity Sales — Jun 30, 2025 Risk: medium
On June 27, 2025, Jaguar Health, Inc. entered into a material definitive agreement, creating a direct financial obligation. The company also reported on unregis
Jaguar Health Files 8-K: Agreements, Obligations, Equity Sales — Jun 24, 2025 Risk: medium
On June 24, 2025, Jaguar Health, Inc. filed an 8-K report detailing several significant events. These include entering into a material definitive agreement, cre
Jaguar Health Files 8-K: Material Agreement, Equity Sales — May 22, 2025 Risk: medium
On May 20, 2025, Jaguar Health, Inc. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and prov
Jaguar Health Reports Financial Obligations and Equity Sales — May 15, 2025 Risk: medium
On May 13, 2025, Jaguar Health, Inc. entered into a material definitive agreement, likely related to its financial obligations. The company also reported on its
Jaguar Health Files 8-K with Financials and Exhibits — May 9, 2025 Risk: low
On May 9, 2025, Jaguar Health, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with a Regulation FD Disclosure.
Jaguar Health Files 8-K: Material Agreement & Financials — May 5, 2025 Risk: low
On May 5, 2025, Jaguar Health, Inc. filed an 8-K report detailing a material definitive agreement and financial statements. The company, formerly known as Jagua
Jaguar Health Files 8-K on Equity Sales — May 2, 2025 Risk: medium
On April 30, 2025, Jaguar Health, Inc. filed an 8-K report detailing unregistered sales of equity securities. The filing also includes financial statements and
Jaguar Health Files 8-K with Financials and Exhibits — Apr 30, 2025 Risk: low
On April 30, 2025, Jaguar Health, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with other events and a Regul
Jaguar Health Files 8-K with Exhibits — Apr 28, 2025 Risk: low
On April 28, 2025, Jaguar Health, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with a Regulation FD disclosu
8-K Filing — Apr 21, 2025
Jaguar Health Files 8-K: Regulatory, Other Events & Financials — Apr 4, 2025 Risk: medium
Jaguar Health, Inc. filed an 8-K on April 4, 2025, reporting events as of March 31, 2025. The filing includes information related to Regulation FD Disclosure, O
Jaguar Health Files 8-K: Agreements, Obligations, Equity Sales — Mar 26, 2025 Risk: medium
On March 26, 2025, Jaguar Health, Inc. filed an 8-K report detailing several significant events. These include entering into a material definitive agreement, cr
Jaguar Health Files 8-K on Security Holder Rights — Mar 18, 2025 Risk: medium
On March 18, 2025, Jaguar Health, Inc. filed an 8-K report detailing material modifications to the rights of its security holders and amendments to its articles
Jaguar Health Files 8-K: Shareholder Vote & Financials — Mar 13, 2025 Risk: low
On March 13, 2025, Jaguar Health, Inc. filed an 8-K report detailing a submission of matters to a vote of security holders, a Regulation FD disclosure, and fina
Jaguar Health Files 8-K on Key Corporate Changes — Feb 27, 2025 Risk: medium
On February 26, 2025, Jaguar Health, Inc. filed an 8-K report detailing several significant events. These include the entry into a material definitive agreement
Jaguar Health Files 8-K on New Agreement and Accountant Change — Feb 20, 2025 Risk: medium
Jaguar Health, Inc. filed an 8-K on February 20, 2025, reporting on two key events that occurred on February 19, 2025. The company entered into a Material Defin
Jaguar Health Files 8-K on Definitive Agreement & Equity Sales — Feb 4, 2025 Risk: medium
On January 28, 2025, Jaguar Health, Inc. entered into a material definitive agreement related to the creation of a direct financial obligation. The company also
Jaguar Health Files 8-K on Financials — Aug 13, 2024 Risk: low
On August 13, 2024, Jaguar Health, Inc. filed an 8-K report. The filing primarily concerns the company's financial condition and results of operations, along wi
Jaguar Health Files 8-K: Corporate Details Updated — Jul 23, 2024 Risk: low
On July 23, 2024, Jaguar Health, Inc. filed an 8-K report detailing a Regulation FD Disclosure and Financial Statements and Exhibits. The filing includes inform
Jaguar Health Enters Material Definitive Agreement — Jul 18, 2024 Risk: medium
On July 17, 2024, Jaguar Health, Inc. entered into a material definitive agreement. The filing also includes financial statements and exhibits related to this a
Jaguar Health Raises $1.5M in Private Placement — Jul 16, 2024 Risk: medium
Jaguar Health, Inc. announced on July 15, 2024, the closing of a private placement of its common stock, raising approximately $1.5 million. The company also iss
Jaguar Health CFO Resigns, Interim Appointed — Jun 26, 2024 Risk: medium
On June 25, 2024, Jaguar Health, Inc. filed an 8-K report detailing the resignation of its Chief Financial Officer, Arthur J. Sim. The company also announced th
Jaguar Health Files 8-K on Shareholder Votes & Financials — Jun 21, 2024 Risk: low
Jaguar Health, Inc. filed an 8-K on June 21, 2024, reporting on matters submitted to a vote of security holders, Regulation FD disclosures, and financial statem
Jaguar Health Reports Unregistered Equity Sales — Jun 10, 2024 Risk: medium
Jaguar Health, Inc. filed an 8-K on June 10, 2024, reporting unregistered sales of equity securities. The filing details transactions that occurred on June 7, 2
Jaguar Health Files 8-K: Stock, Bylaws, and Agreements Updated — May 23, 2024 Risk: medium
On May 17, 2024, Jaguar Health, Inc. entered into a Material Definitive Agreement related to its common stock. The company also made modifications to the rights
Jaguar Health Files 8-K on Shareholder Votes & Disclosures — Apr 9, 2024 Risk: low
Jaguar Health, Inc. filed an 8-K on April 9, 2024, to report on matters submitted to a vote of security holders, Regulation FD disclosures, and other events. Th
Jaguar Health Sells $1M in Stock to Institutional Investor — Mar 21, 2024 Risk: medium
On March 18, 2024, Jaguar Health, Inc. reported an unregistered sale of equity securities. The company entered into a securities purchase agreement with an inst
Jaguar Health Sells $500K in Stock Privately — Mar 8, 2024 Risk: medium
On March 5, 2024, Jaguar Health, Inc. filed an 8-K report detailing an unregistered sale of equity securities. The company issued 1,000,000 shares of its common
Jaguar Health Files 8-K: Material Agreements & Equity Sales — Mar 1, 2024 Risk: medium
On February 27, 2024, Jaguar Health, Inc. entered into a Material Definitive Agreement related to the creation of a direct financial obligation. The company als
Jaguar Health Faces Potential Delisting from NASDAQ — Feb 16, 2024 Risk: high
Jaguar Health, Inc. (NASDAQ: JAGX) filed an 8-K on February 15, 2024, regarding a notice of delisting or failure to satisfy a continued listing rule or standard

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX